Source: Annual Congress 2003 - Fundamental research in developing new drugs
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. S. Hogg, S. A. Mulrennan, A. H. Morice (Hull, United Kingdom). Serum magnesium levels of patients with chronic obstructive pulmonary disease. Eur Respir J 2003; 22: Suppl. 45, 743

Member's Comments

No comment yet.

Related content which might interest you: Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002 Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Serum amyloid A in patients with stable chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 The levels of serum malonyldialhyde and paraoxonase in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005 Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Association between serum YKL-40 and chronic obstructive pulmonary disease Source: International Congress 2017 – COPD biomarkers Year: 2017 Low testosterone in chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 Increased urinary l-histidine in patients with asthma–chronic obstructive pulmonary disease overlap Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Factors affecting C-reactive protein levels in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Plasma orexin-A level and body composition in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 485s Year: 2001 Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Blood MCP-1 levels are increased in chronic obstructive pulmonary disease with prevalent emphysema Source: International Congress 2018 – Biomarkers of COPD Year: 2018 IL-8 in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 364s Year: 2001 Simvastatin does not reduce levels of inflammatory blood markers in patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Inferon administration to patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Circulating tumor cells in chronic obstructive pulmonary disease patients Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011